Sign Up to like & get
recommendations!
0
Published in 2018 at "Stem Cell Reports"
DOI: 10.1016/j.stemcr.2018.03.011
Abstract: Summary The first hematopoietic stem and progenitor cells are generated during development from hemogenic endothelium (HE) through trans-differentiation. The molecular mechanisms underlying this endothelial-to-hematopoietic transition (EHT) remain poorly understood. Here, we explored the role of…
read more here.
Keywords:
hdac1 hdac2;
tgf signaling;
endothelial hematopoietic;
hematopoietic transition ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Oncogene"
DOI: 10.1038/onc.2016.344
Abstract: Mutation of p53 is a frequent genetic lesion in pancreatic cancer being an unmet clinical challenge. Mutants of p53 have lost the tumour-suppressive functions of wild type p53. In addition, p53 mutants exert tumour-promoting functions,…
read more here.
Keywords:
p53;
hdac1 hdac2;
pancreatic cancer;
p53 mutants ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-41842-6
Abstract: Both HDAC1 and HDAC2 are class I deacetylases acting as erasers of lysine-acetyl marks on histones and non-histone proteins. Several histone deacetylase inhibitors, either endogenous to the cell, such as the ketogenic β-hydroxybutyrate metabolite, or…
read more here.
Keywords:
hdac2;
iec;
hdac1 hdac2;
hdac2 independently ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Nucleic Acids Research"
DOI: 10.1093/nar/gkz1136
Abstract: Abstract Despite the rapid development of CRISPR/Cas9-mediated gene editing technology, the gene editing potential of CRISPR/Cas9 is hampered by low efficiency, especially for clinical applications. One of the major challenges is that chromatin compaction inevitably…
read more here.
Keywords:
crispr cas9;
hdac1 hdac2;
gene editing;
cas9 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000000610
Abstract: Histone deacetylases (HDACs) are involved in multiple physical and pathological processes in classical Hodgkin lymphoma (cHL). The prognostic value of HDACs in cHL patients has not been discussed. The aim of the current study is…
read more here.
Keywords:
hdac3 hdac11;
expression;
hdac11;
hdac2 hdac3 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "PLoS Genetics"
DOI: 10.1371/journal.pgen.1010376
Abstract: The class I histone deacetylases are essential regulators of cell fate decisions in health and disease. While pan- and class-specific HDAC inhibitors are available, these drugs do not allow a comprehensive understanding of individual HDAC…
read more here.
Keywords:
acetylation;
class;
hdac1 hdac2;
hdac ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2017.00357
Abstract: Histone deacetylases (HDACs) regulate epigenetic gene expression programs by modulating chromatin architecture and are required for neuronal development. Dysregulation of HDACs and aberrant chromatin acetylation homeostasis have been implicated in various diseases ranging from cancer…
read more here.
Keywords:
hdac2;
hdac2 enzymes;
combinatorial silico;
silico strategy ... See more keywords